Abiraterone acetate for the treatment of metastatic, castrate-resistant prostate cancer following previous cytotoxic chemotherapy

Connock M, Cummins E, Shyangdan D, Hall B, Grove A, Clarke A
Record ID 32011001608
English
Details
Project Status: Completed
Year Published: 2012
Requestor: NIHR Health Technology Assessment programme
English language abstract: An English language summary is available
Publication Type: Full HTA
Country: England, United Kingdom
MeSH Terms
  • Androstenols
  • Androstenes
  • Prostatic Neoplasms
  • Enzyme Inhibitors
  • Abiraterone Acetate
  • Prostatic Neoplasms, Castration-Resistant
  • Androgen Antagonists
  • Antineoplastic Agents
Contact
Organisation Name: NIHR Health Technology Assessment programme
Contact Address: NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name: journals.library@nihr.ac.uk
Contact Email: journals.library@nihr.ac.uk
Copyright: Queen's Printer and Controller of HMSO
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.